Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Yogendra, Ram
134  Ergebnisse:
Personensuche X
?
1

Corrigendum: Case Series: Maraviroc and pravastatin as a th..:

Patterson, Bruce K. ; Yogendra, Ram ; Guevara-Coto, Jose...
Frontiers in Medicine.  11 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Case series: Maraviroc and pravastatin as a therapeutic opt..:

Patterson, Bruce K. ; Yogendra, Ram ; Guevara-Coto, Jose...
Frontiers in Medicine.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in ..:

Patterson, Bruce K. ; Francisco, Edgar B. ; Yogendra, Ram...
Frontiers in Immunology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Immune-Based Prediction of COVID-19 Severity and Chronicity..:

Patterson, Bruce K. ; Guevara-Coto, Jose ; Yogendra, Ram...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
5

Case series: Maraviroc and pravastatin as a therapeutic opt..:

Patterson, Bruce K ; Yogendra, Ram ; Guevara-Coto, Jose...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944830/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in ..:

Patterson, Bruce K ; Francisco, Edgar B ; Yogendra, Ram...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784688/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Immune-Based Prediction of COVID-19 Severity and Chronicity..:

Patterson, Bruce K ; Guevara-Coto, Jose ; Yogendra, Ram...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273732/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Case series: Maraviroc and pravastatin as a therapeutic opt..:

Bruce K. Patterson ; Ram Yogendra ; Jose Guevara-Coto...
https://www.frontiersin.org/articles/10.3389/fmed.2023.1122529/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
9

Image_1_Persistence of SARS CoV-2 S1 Protein in CD16+ Monoc..:

Bruce K. Patterson ; Edgar B. Francisco ; Ram Yogendra...
doi:10.3389/fimmu.2021.746021.s002.  , 2022
Link: https://doi.org/10.3389/..
 
?
10

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in ..:

Bruce K. Patterson ; Edgar B. Francisco ; Ram Yogendra...
https://www.frontiersin.org/articles/10.3389/fimmu.2021.746021/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
11

DataSheet_1_Persistence of SARS CoV-2 S1 Protein in CD16+ M..:

Bruce K. Patterson ; Edgar B. Francisco ; Ram Yogendra...
doi:10.3389/fimmu.2021.746021.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
12

Presentation_1_Immune-Based Prediction of COVID-19 Severity..:

Bruce K. Patterson ; Jose Guevara-Coto ; Ram Yogendra...
doi:10.3389/fimmu.2021.700782.s001.  , 2021
Link: https://doi.org/10.3389/..
 
?
13

Immune-Based Prediction of COVID-19 Severity and Chronicity..:

Bruce K. Patterson ; Jose Guevara-Coto ; Ram Yogendra...
https://www.frontiersin.org/articles/10.3389/fimmu.2021.700782/full.  , 2021
Link: https://doi.org/10.3389/..
 
?
14

Table_1_Immune-Based Prediction of COVID-19 Severity and Ch..:

Bruce K. Patterson ; Jose Guevara-Coto ; Ram Yogendra...
doi:10.3389/fimmu.2021.700782.s002.  , 2021
Link: https://doi.org/10.3389/..
 
?
15

Image_1_Persistence of SARS CoV-2 S1 Protein in CD16+ Monoc..:

Bruce K. Patterson (9961100) ; Edgar B. Francisco (11034978) ; Ram Yogendra (11034975)...
https://figshare.com/articles/figure/Image_1_Persistence_of_SARS_CoV-2_S1_Protein_in_CD16_Monocytes_in_Post-Acute_Sequelae_of_COVID-19_PASC_up_to_15_Months_Post-Infection_tif/18094979.  , 2022
Link: https://doi.org/10.3389/..
 
1-15